# To Evaluate the Safety, Tolerability and PK of GT20029 Gel and Solution in Healthy Subjects

> **NCT06468579** · PHASE1 · COMPLETED · sponsor: **Suzhou Kintor Pharmaceutical Inc,** · enrollment: 92 (actual)

## Conditions studied

- Acne
- Alopecia

## Interventions

- **DRUG:** GT20029
- **DRUG:** GT20029 matching placebo

## Key facts

- **NCT ID:** NCT06468579
- **Lead sponsor:** Suzhou Kintor Pharmaceutical Inc,
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-25
- **Primary completion:** 2022-08-15
- **Final completion:** 2023-04-26
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2024-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06468579

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06468579, "To Evaluate the Safety, Tolerability and PK of GT20029 Gel and Solution in Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06468579. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*